|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
US5206018A
(en)
|
1978-11-03 |
1993-04-27 |
Ayerst, Mckenna & Harrison, Inc. |
Use of rapamycin in treatment of tumors
|
|
US4342828A
(en)
|
1979-07-20 |
1982-08-03 |
Morinaga Milk Industry Co., Ltd. |
Method for producing substance capable of stimulating differentiation and proliferation of human granulopoietic stem cells
|
|
JPS61227526A
(ja)
|
1984-07-25 |
1986-10-09 |
Chugai Pharmaceut Co Ltd |
新規なコロニー刺激因子
|
|
ATE65798T1
(de)
|
1985-02-08 |
1991-08-15 |
Chugai Pharmaceutical Co Ltd |
Menschlicher granuloxcyt-koloniestimulierungsfaktor.
|
|
US4810643A
(en)
|
1985-08-23 |
1989-03-07 |
Kirin- Amgen Inc. |
Production of pluripotent granulocyte colony-stimulating factor
|
|
EP0396158A1
(en)
|
1985-08-23 |
1990-11-07 |
Kirin-Amgen, Inc. |
Production of pluripotent granulocyte colony-stimulating factor
|
|
DE3681551D1
(de)
|
1985-09-30 |
1991-10-24 |
Chugai Pharmaceutical Co Ltd |
Menschlicher granulozyten-colony stimulierender faktor.
|
|
JPH0618778B2
(ja)
|
1985-10-04 |
1994-03-16 |
中外製薬株式会社 |
白血球減少症治療剤
|
|
ES2036530T3
(es)
|
1986-01-22 |
1993-06-01 |
Chugai Seiyaku Kabushiki Kaisha |
Utilizacion de un factor estimulante de las colonias granulociticas humano para preparar una composicion farmaceutica para el tratamiento de la leucemia mielogena.
|
|
EP0230980B2
(en)
|
1986-01-22 |
1996-03-20 |
Chugai Seiyaku Kabushiki Kaisha |
Pharmaceutical agent for promoting the recovery of hemopoietic capacity
|
|
DK203187A
(da)
|
1986-04-22 |
1987-10-23 |
Immunex Corp |
Human g-csf proteinekspression
|
|
JPH0725689B2
(ja)
|
1986-10-07 |
1995-03-22 |
中外製薬株式会社 |
顆粒球コロニ−刺激因子を含有する徐放性製剤
|
|
NO176799C
(no)
|
1986-12-23 |
1995-05-31 |
Kyowa Hakko Kogyo Kk |
DNA som koder for et polypeptid, rekombinant plasmid som koder for og kan uttrykke et polypeptid og fremgangsmåte for fremstilling av dette polypeptid
|
|
JP2618618B2
(ja)
|
1988-03-04 |
1997-06-11 |
協和醗酵工業株式会社 |
抗ｇ−ｃｓｆ誘導体、ｎｄ２８モノクローナル抗体
|
|
CA1340810C
(en)
|
1988-03-31 |
1999-11-02 |
Motoo Yamasaki |
Polypeptide derivatives of human granulocyte colony stimulating factor
|
|
EP0344796B1
(en)
|
1988-06-03 |
1994-09-21 |
Chugai Seiyaku Kabushiki Kaisha |
Crystalline human granulocyte colony stimulating factor and process for preparing the same
|
|
US5202117A
(en)
|
1988-08-24 |
1993-04-13 |
Koichiro Tsuji |
Method of treating thrombi with g-csf
|
|
US5218092A
(en)
|
1988-09-29 |
1993-06-08 |
Kyowa Hakko Kogyo Co., Ltd. |
Modified granulocyte-colony stimulating factor polypeptide with added carbohydrate chains
|
|
US5104651A
(en)
|
1988-12-16 |
1992-04-14 |
Amgen Inc. |
Stabilized hydrophobic protein formulations of g-csf
|
|
WO1990006952A1
(fr)
|
1988-12-22 |
1990-06-28 |
Kirin-Amgen, Inc. |
Facteur de stimulation de colonies de granulocytes modifies chimiquement
|
|
IL96477A0
(en)
|
1989-12-01 |
1991-08-16 |
Amgen Inc |
Megakaryocyte production
|
|
GB9107846D0
(en)
|
1990-04-30 |
1991-05-29 |
Ici Plc |
Polypeptides
|
|
JP3249147B2
(ja)
|
1990-06-01 |
2002-01-21 |
キリン−アムジエン・インコーポレーテツド |
生理活性蛋白含有経口製剤
|
|
EP0459516A1
(en)
|
1990-06-01 |
1991-12-04 |
Kirin-Amgen, Inc. |
Oral dosage form of biologically active proteins
|
|
IE912365A1
(en)
|
1990-07-23 |
1992-01-29 |
Zeneca Ltd |
Continuous release pharmaceutical compositions
|
|
US5250732A
(en)
|
1991-07-18 |
1993-10-05 |
Genentech, Inc. |
Ketamine analogues for treatment of thrombocytopenia
|
|
FR2686900B1
(fr)
|
1992-01-31 |
1995-07-21 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides ayant une activite de stimulation des colonies de granulocytes, leur preparation et compositions pharmaceutiques les contenant.
|
|
JPH08504837A
(ja)
|
1993-10-14 |
1996-05-28 |
生化学工業株式会社 |
新規ポリペプチドおよびこれから調製される抗ｈｉｖ剤
|
|
US5595756A
(en)
|
1993-12-22 |
1997-01-21 |
Inex Pharmaceuticals Corporation |
Liposomal compositions for enhanced retention of bioactive agents
|
|
US5492126A
(en)
|
1994-05-02 |
1996-02-20 |
Focal Surgery |
Probe for medical imaging and therapy using ultrasound
|
|
JP4562815B2
(ja)
*
|
1997-05-21 |
2010-10-13 |
ジェネンテック， インコーポレイテッド |
トロンボポエチンの新規な投与
|
|
ATE419789T1
(de)
|
1997-05-23 |
2009-01-15 |
Prorhythm Inc |
Wegwerfbarer fokussierender ultraschallapplikator hoher intensität
|
|
US6569418B1
(en)
|
1997-12-11 |
2003-05-27 |
University Of Maryland Biotechnology Institute |
Immuno-modulating effects of chemokines in DNA vaccination
|
|
WO2000009152A1
(en)
|
1998-08-14 |
2000-02-24 |
The University Of British Columbia |
Therapeutic chemokine receptor antagonists
|
|
CA2245224A1
(en)
|
1998-08-14 |
2000-02-14 |
Jiang-Hong Giong |
Chemokine receptor antagonists and chemotherapeutics
|
|
CA2305787A1
(en)
|
2000-05-09 |
2001-11-09 |
The University Of British Columbia |
Cxcr4 antagonist treatment of hematopoietic cells
|
|
JP2002506830A
(ja)
|
1998-03-13 |
2002-03-05 |
ザ ユニバーシティ オブ ブリティッシュ コロンビア |
治療的ケモカイン受容体アンタゴニスト
|
|
WO2000006086A2
(en)
|
1998-07-31 |
2000-02-10 |
The Trustees Of Columbia University In The City Of New York |
Use of inhibitors of the activation of cxcr4 receptor by sdf-1 in treating rheumatoid arthritis
|
|
SK4272001A3
(en)
|
1998-10-05 |
2003-02-04 |
Pharmexa As |
Methods for therapeutic vaccination
|
|
US6576875B1
(en)
|
1998-10-27 |
2003-06-10 |
Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E. V |
Method and device for controlling a targeted thermal deposition into a material
|
|
US20060079492A1
(en)
|
1999-10-25 |
2006-04-13 |
Ahlem Clarence N |
Compositions and treatment methods
|
|
US6365583B1
(en)
|
1999-02-02 |
2002-04-02 |
Anormed, Inc. |
Methods to enhance white blood cell count
|
|
WO2000057861A2
(en)
|
1999-03-29 |
2000-10-05 |
Shire Biochem Inc. |
Use of cytidine derivatives for the treatment of leukaemia
|
|
EP2261256A3
(en)
|
1999-11-24 |
2011-03-02 |
Schering Corporation |
Methods of inhibiting metastasis
|
|
AU2001236065A1
(en)
|
2000-03-03 |
2001-09-12 |
Nobutaka Fujii |
Antiviral compounds
|
|
EP1286684B1
(en)
*
|
2000-05-09 |
2004-04-28 |
The University Of British Columbia |
use of cxcr4 antagonists for treating autoimmune diseases and cancer
|
|
DE60136373D1
(de)
|
2000-09-05 |
2008-12-11 |
Biokine Therapeutics Ltd |
Neue polypeptide und anti-hiv-arzneimittel, die diese enthalten
|
|
US8435939B2
(en)
|
2000-09-05 |
2013-05-07 |
Biokine Therapeutics Ltd. |
Polypeptide anti-HIV agent containing the same
|
|
US20020159996A1
(en)
|
2001-01-31 |
2002-10-31 |
Kandasamy Hariharan |
Use of CD23 antagonists for the treatment of neoplastic disorders
|
|
US7630750B2
(en)
|
2001-02-05 |
2009-12-08 |
The Research Foundation For The State University Of New York |
Computer aided treatment planning
|
|
JP3374917B2
(ja)
|
2001-02-16 |
2003-02-10 |
サンケン電気株式会社 |
スイッチング電源装置
|
|
US7169750B2
(en)
|
2001-07-31 |
2007-01-30 |
Anormed, Inc. |
Methods to mobilize progenitor/stem cells
|
|
US20030221931A1
(en)
|
2002-02-28 |
2003-12-04 |
Steve Marsh |
Sliding device
|
|
US8774913B2
(en)
|
2002-04-08 |
2014-07-08 |
Medtronic Ardian Luxembourg S.A.R.L. |
Methods and apparatus for intravasculary-induced neuromodulation
|
|
AU2003261723A1
(en)
|
2002-08-27 |
2004-03-19 |
Takeda Chemical Industries, Ltd. |
Cxcr4 antagonist and use thereof
|
|
DE10240064A1
(de)
|
2002-08-30 |
2004-03-11 |
Universitätsklinikum Freiburg |
CXCR4-Rezeptor-Antagonisten
|
|
EP1571146A4
(en)
|
2002-12-10 |
2010-09-01 |
Ono Pharmaceutical Co |
NITROGENIC HETEROCYCLIC COMPOUNDS AND THEIR MEDICAL USE
|
|
US20050002939A1
(en)
|
2002-12-23 |
2005-01-06 |
Albert Zlotnik |
Tumor killing/tumor regression using CXCR4 antagonists
|
|
JP2006524242A
(ja)
*
|
2003-03-27 |
2006-10-26 |
エモリー ユニバーシティー |
Ｃｘｃｒ４アンタゴニストおよびそれらの使用方法
|
|
WO2004091518A2
(en)
|
2003-04-11 |
2004-10-28 |
Anormed Inc. |
Cxcr4 chemokine receptor binding compounds
|
|
US8545463B2
(en)
|
2003-05-20 |
2013-10-01 |
Optimyst Systems Inc. |
Ophthalmic fluid reservoir assembly for use with an ophthalmic fluid delivery device
|
|
KR100773259B1
(ko)
|
2004-03-19 |
2007-11-05 |
모리나가 뉴교 가부시키가이샤 |
암치료를 위한 약제
|
|
JP2008509928A
(ja)
|
2004-08-13 |
2008-04-03 |
アノーメド インコーポレイテッド |
前駆／幹細胞を動員するためのケモカインの組み合わせ
|
|
US20080233053A1
(en)
|
2005-02-07 |
2008-09-25 |
Pharmalight Inc. |
Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients
|
|
US20070043012A1
(en)
|
2005-08-19 |
2007-02-22 |
Bridger Gary J |
Methods to enhance chemotherapy
|
|
WO2007067280A2
(en)
|
2005-12-08 |
2007-06-14 |
University Of Louisville Research Foundation, Inc. |
Very small embryonic-like (vsel) stem cells and methods of isolating and using the same
|
|
US20080038231A1
(en)
|
2006-06-15 |
2008-02-14 |
Rodgerson Denis O |
Processing procedure for peripheral blood stem cells
|
|
US20100003224A1
(en)
|
2006-08-02 |
2010-01-07 |
Genzyme Corporation |
Combination Therapy
|
|
WO2008016141A1
(fr)
|
2006-08-04 |
2008-02-07 |
Kurume University |
Peptide dérivé de kif capable de se lier à une molécule hla-a24
|
|
WO2008075371A2
(en)
|
2006-12-21 |
2008-06-26 |
Biokine Therapeutics Ltd. |
T-140 peptide analogs having cxcr4 super-agonist activity for immunomodulation
|
|
BRPI1009663A2
(pt)
|
2009-06-14 |
2016-10-11 |
Biokine Therapeutics Ltd |
"método para elevação dos níveis plaquetários em um indivíduo com essa necessidade, método de inibição de hemorragia em um indivíduo que a necessite e composição farmacêutica"
|
|
CN102482324B
(zh)
|
2009-06-15 |
2014-07-02 |
拜欧肯疗法有限公司 |
能够抑制自身免疫、炎症和癌症进程的新型趋化因子结合多肽
|
|
US20120082687A1
(en)
|
2010-10-04 |
2012-04-05 |
Alex Wah Hin Yeung |
Use of cell adhesion inhibitor for the mobilization of antigen presenting cells and immune cells in a cell mixture (AIM) from the peripheral blood and methods of use
|
|
US20130303460A1
(en)
|
2011-01-10 |
2013-11-14 |
Biokine Therapeutics Ltd. |
Peptides and compositions for the treatment of neuroectodermal derived tumors and retinoblastoma
|
|
EP2841084B1
(en)
|
2012-04-24 |
2018-05-30 |
Biokine Therapeutics Ltd. |
Cxcr4 antagonist peptide for use in the treatment of large cell lung cancer
|
|
JP6294459B2
(ja)
|
2013-03-24 |
2018-03-14 |
バイオカイン・セラピューティクス・リミテッドＢｉｏｋｉｎｅ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｔｄ． |
骨髄性白血病の処置方法
|
|
CA2920377A1
(en)
|
2013-08-05 |
2015-02-12 |
Cambridge Enterprise Limited |
Inhibition of cxcr4 signaling in cancer immunotherapy
|
|
ES2811804T3
(es)
|
2013-10-31 |
2021-03-15 |
Biokine Therapeutics Ltd |
Un inhibidor peptídico de CXCR4 para su uso en el tratamiento de la leucemia mieloide aguda con una mutación de FLT3
|